LA 20% Umjovo we-Oxytetracycline

Incazelo emfushane:

Ukubukeka:Uketshezi olucacile oluphuzi kuya kokunsundu ngokukhanyayo.

Ukwakhiwa:I-1 ml iqukethe i-Oxytetracycline elingana no-200 mg.

Ukuphatha:Umjovo we-Intramuscular

Izinkomba:

Izimvu, Imbuzi Nezinkomo: izifo zokuphefumula, i-mastitis, i-metritis, i-chlamydiosis, kanye nezifo ze-cornea, conjunctiva kanye nokutheleleka kwesilonda

Izinkukhu: Isifo sokuphefumula esingamahlalakhona (CRD) Colibacillosis kanye nekholera yezinyoni

Izitifiketi:I-GMP&ISO

Isevisi:OEM & ODM

Ukupakisha:10ml, 20ml, 50ml, 100ml, 250ml, 500ml

Imali yokuthengisa ye FOB	US $0.5 – 9,999 / Ucezu
Inani elincane le-oda	1 Ucezu/Izingcezu
Supply Amandla	10000 Ucezu/Izingcezu Ngenyanga
Isikhathi sokukhokha	T/T, D/P, D/A, L/C

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Iphrofayela Yenkampani

Omaka bomkhiqizo

Ukwakheka

1 ml kweUmjovo we-LA Oxytetracycline 20%iquketheI-Oxytetracyclinei-dihydrate elingana nesisekelo esingu-200 mg.

Inkomba

Ukusetshenziswa kwe-tetracycline kuboniswa ezifweni zesistimu nezendawo ezifana ne-Bronchopneumon ia, i-bacterial enteritis, izifo ze-urinary tract, i-cholang itis, i-Metritis, i-mastitis, i-pyodermia, i-Anthrax, i-Diphtheria ne-CRD.

Izinkomba eziqondile zezimvu, Imbuzi Nezinkomo izifo zokuphefumula, i-mastitis, i-metritis, i-chlamydiosis, kanye nezifo ze-cornea, conjunctiva kanye nezilonda;
Izinkomba eziqondile zezinkukhu yisifo esingamahlalakhona sokuphefumula (CRD) Colibacillosis kanye nekholera yezinyoni.

Umthamo

Umthamo ojwayelekile ngu: 10-20mg/kg isisindo somzimba, nsuku zonke.

Abantu abadala: 0.5ml/10kg, izilwane ezincane 1ml/10kg isisindo somzimba

Izinkomo, ikamela, izimvu, izimbuzi: umjovo owodwa ngomthamo wama-20 mg we-oxytetracycline ngekhilogremu yesisindo somzimba noma 1 ml nge-10 kg yesisindo somzimba

Umzila wokuphatha

Umjovo we-Intramuscular

Isikhawu somthamo

Phinda Umjovo wesibili ngemva kwezinsuku ezingu-2-4

I-Toxicology

Imiphumela eyingozi ngenxa yokusetshenziswa kwe-tetracycline ayivame ukubonwa

Imiphumela emibi

Imiphumela emibi ngenxa yokusetshenziswa kwe-tetracycline yilezi: ukungezwani komzimba, i-photosensitivity, ukuguquguquka kwamazinyo eqenjini lentsha kanye ne-hepatoxicity, i-oxytetracycline nayo ingabangela ukucasuka kwezicubu endaweni yomjovo.

Contra inkomba

I-contra-indication yokusetshenziswa kwe-tetracycline ukulimala okukhulu kwesibindi noma izinso kanye ne-hypersensitivity ku-tetracycline ngezikhathi ezithile.

I-Therapeutic incom patibilities

I-Tetracycline akufanele ihlanganiswe nemithi elwa namagciwane efana ne-penicill1nes, i-cephalosporins.Ukumuncwa kwe-tetracycline kuyavinjwa uma kunikezwa ngasikhathi sinye namalungiselelo aqukethe ama-divalent cations.Inhlanganisela ye-tetracycline nama-macrolides njenge-tylosin nama-polymyxins njenge-colistin, isebenza ngokubambisana

Isikhathi sokuhoxiswa eselulekiwe

Inyama: izinsuku ezingama-21
Ubisi, Amaqanda: izinsuku ezingu-07

Ukuphawula

Gcina ngaphansi kuka-25℃, vikela ekukhanyeni.
Gcina endaweni lapho izingane zingafinyeleleki khona.
Ungasebenzisi uma isixazululo siba ne-turbid noma siba mnyama.
Hlala uthintana nodokotela wakho wezilwane ngaphambi kokusebenzisa umuthi.

Okwedlule: 4% umjovo we-Gentamyclin sulphate

Olandelayo: 5% Umjovo we-Oxytetracycline

I-Hebei Veyong Pharmaceutical Co., Ltd, yasungulwa ngo-2002, etholakala eShijiazhuang City, eSifundazweni saseHebei, eChina, eduze kweNhloko-dolobha yaseBeijing.Uyibhizinisi elikhulu lemithi yezilwane eqinisekiswe yi-GMP, ene-R&D, ukukhiqizwa nokudayiswa kwama-API wezilwane, amalungiselelo, okuphakelayo okuxutshwe ngaphambili nezithasiselo zokudla.NjengeSikhungo Sezobuchwepheshe Sesifundazwe, i-Veyong isungule uhlelo olusha lwe-R&D lomuthi omusha wezilwane, futhi iyibhizinisi lezobuchwepheshe elaziwa kuzwelonke elisekelwe kudokotela wezilwane, kunochwepheshe abangama-65.I-Veyong inezisekelo ezimbili zokukhiqiza: i-Shijiazhuang ne-Ordos, lapho isisekelo se-Shijiazhuang sihlanganisa indawo engu-78,706 m2, nemikhiqizo ye-API engu-13 ehlanganisa i-Ivermectin, i-Eprinomectin, i-Tiamulin Fumarate, i-Oxytetracycline hydrochloride ects, kanye ne-11, imigqa yokukhiqiza ye-powder yokulungiselela , premix, bolus, izibulala-zinambuzane nesibulala-magciwane, njll.I-Veyong ihlinzeka ngama-API, amalungiselelo angaphezu kwe-100 elebula uqobo, kanye nesevisi ye-OEM & ODM.

I-Veyong ibheka ukubaluleka okukhulu ekuphathweni kohlelo lwe-EHS(Imvelo, Impilo Nokuphepha), futhi yathola izitifiketi ze-ISO14001 ne-OHSAS18001.I-Veyong isohlwini lwamasu amabhizinisi ezimboni asafufusa esifundazweni sase-Hebei futhi ingaqinisekisa ukuhlinzekwa okuqhubekayo kwemikhiqizo.

I-Veyong yasungula uhlelo oluphelele lokuphatha ikhwalithi, yathola isitifiketi se-ISO9001, isitifiketi se-China GMP, isitifiketi se-APVMA GMP yase-Australia, isitifiketi se-Ethiopia GMP, isitifiketi se-Ivermectin CEP, futhi yaphumelela ukuhlolwa kwe-US FDA.I-Veyong inethimba elichwepheshile lokubhalisa, ukuthengisa kanye nenkonzo yezobuchwepheshe, inkampani yethu ithole ukwethenjwa nokusekelwa kumakhasimende amaningi ngekhwalithi yomkhiqizo omuhle kakhulu, ikhwalithi ephezulu yokuthengisa kwangaphambili kanye nenkonzo yangemuva kokuthengisa, ukuphathwa okungathi sína nokwesayensi.I-Veyong yenze ukubambisana kwesikhathi eside namabhizinisi amaningi emithi yezilwane aziwa emhlabeni wonke ngemikhiqizo ethunyelwa eYurophu, eNingizimu Melika, eMpumalanga Ephakathi, e-Afrika, e-Asia, njll. emazweni nasezifundeni ezingaphezu kuka-60.